PROCLARA BIOSCIENCES, INC. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-11-30. The offering totals $47.0M, of which $43.0M was reported sold. Industry: Biotechnology.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| John Dee | Director | Cambridge, MA |
| Paul Goldenheim, MD | Director | Cambridge, MA |
| Franz Hefti, Ph.D. | Director | Cambrdige, MA |
| Nick Leschly | Director | Cambridge, MA |
| Daniel Lynch | Director | Greenfield, IN |
| Hans Schoepflin | Director | Cambridge, MA |
| Peter Smedvig | Director | Cambridge, MA |
| Richard Fischer, Ph.D. | Executive Officer | Cambridge, MA |
| Franz Hefti, Ph.D. | Executive Officer | Cambrdige, MA |
| Hampus Hillerstrom | Executive Officer | Cambridge, MA |
| Jonathan Solomon | Director | Ness Ziona, L3 |
| Jonathan Solomon | Executive Officer | Ness Ziona, L3 |
| Vicki Sato | Director | San Francisco, CA |
| Paul Goldenheim | Director | Allston, MA |
| Valerie A Calenda, Ph.D. | Director | Cambridge, MA |
| Franz A Hefti, Ph.D. | Director | Cambridge, MA |
| Richard A Fisher, Ph.D. | Director | Cambridge, MA |
| Richard A Fisher, Ph.D. | Executive Officer | Cambridge, MA |
| Kenneth A Buckfire | Director | Cambridge, MA |
| David A Michelson, M.D. | Director | Cambridge, MA |
| Hampus Hillerstrom | Director | Cambridge, MA |
| Francois Valencony | Director | Cambridge, MA |
| Kenneth Buckfire | Director | Cambridge, MA |
| Nico Dosenbach | Director | Cambridge, MA |
| Valerie Calenda | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2018-11-16 | D | $10.0M | $6.9M |
| 2014-04-04 | D | $17.1M | $5.7M |
| 2013-03-27 | D | $8.3M | $3.7M |
| 2012-03-20 | D | $9.0M | $9.0M |
| 2011-03-09 | D | $12.4M | $8.4M |